Vicor vs Varex Imaging
VICR and VREX side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How VICR and VREX compare
Vicor is the larger company, worth 9.6 times as much as Varex Imaging ($7.3B against $762M).
On earnings, Varex Imaging is cheaper: it trades at 34.8× trailing earnings, against 41.6× for Vicor.
Vicor grew revenue faster over the last twelve months (27.0% versus 5.3% for Varex Imaging).
Vicor keeps more of each dollar of sales as profit, with a net margin of 32.2% compared with 2.6% at Varex Imaging.
Vicor scores higher on the StockData Score (17 against 7 for Varex Imaging), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | VICR | VREX |
|---|---|---|
| Size and price | ||
| Market cap | $7.3B | $762M |
| Share price | $159.05 | $18.10 |
| Change, 1 year | 68.6% | 46.6% |
| Change, 5 years | 0.16% | −38.7% |
| Beta (5Y) | 2.01 | 1.13 |
| Employees | 1,092 | 400 |
| StockData Score | ||
| Total score | 17 (better) | 7 |
| Valuation score | 2 | 3 (better) |
| Growth score | 4 (better) | 1 |
| Performance score | 5 (better) | 1 |
| Health score | 6 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 41.6× | 34.8× (better) |
| P/S | 13.1× | 0.9× (better) |
| P/B | 8.1× | 1.5× (better) |
| EV/EBITDA | 42.4× | 14.2× (better) |
| P/FCF | 144× | – |
| PEG | 0.63 | – |
| FCF yield | 0.69% (better) | −2.7% |
| Fair value | $137.83 | $19.43 |
| Margin of safety | −15.4% | 6.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 27.0% (better) | 5.3% |
| Revenue growth, 5Y average | 8.8% (better) | 2.7% |
| Net income growth (TTM) | 119% | – |
| EPS growth (TTM) | 110% | – |
| EPS growth, 5Y average | 44.8% | – |
| Profitability | ||
| Gross margin | 60.6% (better) | 34.3% |
| Operating margin | 24.9% (better) | 8.3% |
| Net margin | 32.2% (better) | 2.6% |
| FCF margin | 9.1% (better) | −2.3% |
| Return on equity | 23.5% (better) | 4.6% |
| Return on invested capital | 42.2% (better) | 8.3% |
| Financial health | ||
| Debt / equity | 0.00 | 0.70 (better) |
| Net debt / EBITDA | – | 3.43 |
| Interest coverage | – | 1.9× |
| Current ratio | 11.44 (better) | 3.38 |
| Altman Z-score | 61.36 (better) | 2.27 |
| Piotroski F-score | 8 (better) | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 47.6% | 96.2% |
| Held by insiders | 46.0% | 2.0% |
| Insider net buying, 12 months | −$410M | −$2.6M (better) |
| Short interest, % of float | 8.6% | 4.9% |
Go deeper
- VICR stock overview
- VICR income statement
- VICR valuation and score
- VREX stock overview
- VREX income statement
- VREX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.